Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. ORCL
3. USO
4. LLY
5. KKR
6. DAVA
7. PSKY
8. MONC:IM
9. PTON
10. NYXH

Go back to Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
(NASDAQ: AXSM) Delayed: 205.49 --0 (-0%)
Previous Close $205.49    52 Week High $15.74 
Open $205.49    52 Week Low $5.37 
Day High $205.49    P/E N/A 
Day Low $205.49    EPS $0.00 
Volume 1,472